Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 9(126), p. 1362-1362, 2022
DOI: 10.1038/s41416-022-01772-z
Springer Nature [academic journals on nature.com], British Journal of Cancer, 10(124), p. 1746-1746, 2021
DOI: 10.1038/s41416-021-01312-1
Links
- Springer Nature [academic journals on nature.com] | PDF
- Springer Nature [academic journals on nature.com] | PDF
Tools
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis
Journal article published in 2021 by
Jesper van Breeschoten,
Astrid A. M. van der Veldt 
,
Michel W. J. M. Wouters,
Doranne L. Hilarius,
John B. Haanen,
Christian U. Blank,
Maureen J. B. Aarts,
Franchette W. P. J. van den Berkmortel,
Jan-Willem B. de Groot,
Geke A. P. Hospers,
Ellen Kapiteijn,
Djura Piersma,
Roos S. van Rijn,
Karijn P. M. Suijkerbuijk,
Willeke A. M. Blokx
and other authors.
,
Michel W. J. M. Wouters,
Doranne L. Hilarius,
John B. Haanen,
Christian U. Blank,
Maureen J. B. Aarts,
Franchette W. P. J. van den Berkmortel,
Jan-Willem B. de Groot,
Geke A. P. Hospers,
Ellen Kapiteijn,
Djura Piersma,
Roos S. van Rijn,
Karijn P. M. Suijkerbuijk,
Willeke A. M. Blokx
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 